Update of PDE5 inhibitors for the treatment of ischemia-reperfusion

Yang-Yang HU; Zhi-Gang WU

Update of PDE5 inhibitors for the treatment of ischemia-reperfusion / 中华男科学杂志

Yang-Yang HU; Zhi-Gang WU.

National Journal of Andrology ; (12): 842-846, 2011.

Article in Chinese | WPRIM | ID: wpr-305776

ABSTRACT

ABSTRACT

Phosphodiesterase type 5 (PDE5) inhibitors are used most commonly in the treatment of penile erectile dysfunction (ED). Recent studies show that PDE5 inhibitors are ideal drugs for treating ischemia-reperfusion injury. This review focuses on the results of basic and clinical researches on PDE5 inhibitors for the treatment of ischemia-reperfusion injury and provides some theoretical evidence for clinical options of the drugs.

Subject(s)

Humans; Male; Erectile Dysfunction; Drug Therapy; Phosphodiesterase 5 Inhibitors; Therapeutic Uses; Phosphodiesterase Inhibitors; Therapeutic Uses; Reperfusion Injury; Drug Therapy

Fulltext

XML

Search on Google

Full text: Available Index: WPRIM (Western Pacific) Main subject: Phosphodiesterase Inhibitors / Reperfusion Injury / Therapeutic Uses / Drug Therapy / Phosphodiesterase 5 Inhibitors / Erectile Dysfunction Limits: Humans / Male Language: Chinese Journal: National Journal of Andrology Year: 2011 Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google